Aprutumab ixadotin
Product Specifications
CAS Number
1708947-48-1
Target
FGFR|||Antibody-Drug Conjugates (ADCs) |||Apoptosis|||Microtubule Associated
Related Pathways
Tyrosine Kinase/Adaptors|||Angiogenesis|||Cytoskeletal Signaling|||Antibody-drug Conjugate/ADC Related|||Apoptosis
Bioactivity
Aprutumab ixadotin (BAY 1187982) is the first antibody-drug conjugate (ADC) targeting FGFR2, and is also the inaugural ADC to employ an auristatin-based active payload.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6314379-01 0.1 mL
KLRC1, NT (KLRC1, NKG2A, NKG2-A/NKG2-B type II integral membrane protein, CD159 antigen-like family member A, NK cell receptor A, NKG2-A/B-activating NK receptor, CD159a) (MaxLight 750)
Ask
View Details 
MBS6314379-02 5x 0.1 mL
KLRC1, NT (KLRC1, NKG2A, NKG2-A/NKG2-B type II integral membrane protein, CD159 antigen-like family member A, NK cell receptor A, NKG2-A/B-activating NK receptor, CD159a) (MaxLight 750)
Ask
View Details C2444-12A 1 mL
CD99 (MIC2, p30/32MIC2, Ewing’s Sarcoma Marker, E2 Antigen) discontinued
Ask
View Details 